Browsing Tag
Serum Institute of India
24 posts
Discussed Enhancing capacities to Prepare for Future Pandemic: Poonawalla
Coming out of the meeting, Poonawalla said that it (achieving the 100 crore mark was "a historic moment", and the industry worked together with the vision of PM Modi to materialise it.
US Policy Change to Boost Vaccines Production: Adar Poonawalla
Earlier on April 16, Poonawalla had tweeted for lifting the embargo on raw materials.
Opening Covid Vaccine for multiple age groups created scarcity: SII
On the efficacy of vaccines, Jadhav stated that the selection of vaccines is based on the CDC and NIH data.
Plea in High Court seeks Z-plus security for SII CEO Adar Poonawalla
A petition filed in the Bombay High Court has sought Z-plus security for Adar Poonawalla, Chief Executive Officer…
Adar Poonawalla To Invest Over $300 Million In UK
The Serum Institute of India (SII) has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot.
COVID-19: In a ‘philanthropic gesture’ SII cuts Covishield vaccine price for states to Rs 300 per dose
The gesture came after widespread criticism of its pricing policy and the Supreme Court putting the Centre on the mat, asking it to control the vaccine prices in two days
COVID-19 Vaccine: Serum Institute issues clarification on Covishield pricing, says Govt Procurement is at ‘far Lower Price’
"Covishield is the most affordable COVID-19 vaccine available in the market today. The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing," Serum India said in a statement.
Nepal to procure 2 mn vaccines from India at subsidised rate
Earlier in January, Nepal had received one million doses of Covid vaccine from India on a grant, and nationwide immunisation is underway in the country for frontline workers and others.
No vaccine approval yet, drug regulator analysing SII, Bharat Biotech data
On December 9, the Subject Expert Committee had asked the SII and Bharat Biotech to submit more data and information to get approval.
Serum Institute of India launches world’s most affordable pneumococcal conjugate vaccine
Serum Institute of India, which is the world's largest vaccine maker by volume, has priced pneumococcal conjugate vaccine, branded as Pneumosil, at $3 per dose for public market and little over $10 per dose for private market.
Adar Poonawalla, CEO Serum Institute among 6 named ‘Asians of the Year’ by Singapore daily
The Serum Institute was founded by Poonawalla's father Cyrus Poonawalla in 1966.
SII to seek emergency use authorisation for AstraZeneca Covid vaccine in 2 weeks: Poonawalla
New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19…
PM reviews vaccine progress at Serum Institute in Pune
Pune, Nov 28: Prime Minister Narendra Modi on Saturday evening visited the Serum Institute of India (SII) here,…
Oxford vaccine viable even at 60-70% efficacy: Serum Institute
The PM visit will be followed by a visit by ambassadors and High Commissioners from around 100 countries, Pune Divisional Commissioner Saurabh Rao said.
Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP
The SII has almost completed its phase 3 trials in India and a follow-up of the data is likely to start soon.
Oxford vaccine to cost Rs 500-600, available by April 2021: SII CEO
Could seek govt nod for limited use of ‘Covishield’ in December, may cost Rs 500-600: Serum CEO
What makes a good vaccine? Serum Institute of India CEO Adar Poonawalla explains
Both Pfizer and Moderna’s COVID-19 vaccines, which are waiting for the approval of the regulatory body, are based on mRNA technology.
India may get COVID-19 vaccine by March 2021: Serum Institute of India
Currently, scientists, health researchers and drugmakers all over the world are racing to produce a safe and effective vaccine against coronavirus.
Covid vaccine to be available from January, says Sharad Pawar
SII Chairman Dr Cyrus S. Poonawalla and his son and CEO Adar Poonawala share a close rapport with the Pawar family.
Serum Institute to manufacture 200mn doses of Covid-19 vaccine
As a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate
US-based Novavax's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirus
Serum Institute CEO has a question for govt: ‘Will it have Rs 80k cr to give each Indian Covid vaccine’
Serum Institute of India has the licence to produce and market two of the leading vaccine candidates, one being developed by AstraZeneca and the Oxford University, and the other one by US company Novavax.
Serum Institute to provide Covid vaccine to 92 countries at Rs 250 a dose
Partners with Gavi, Gates Foundation, will provide 100 mn doses to Covax, a WHO initiative led by Gavi and CEPI
Serum Institute of India to apply for Oxford vaccine trials in India in a week
Oxford University's vaccine, called AZD1222, is being manufactured by pharmaceutical major AstraZeneca and the UK government has ordered 100 million doses ahead of time.
Serum Institute CEO says vaccine development is like rollercoaster
Reports of the Oxford vaccine's performance on monkeys had prompted researchers to test the vaccine's potency in humans.